HomeAI · summaries
Storia in 5 fonti
India hikes cancer drug prices by 50% amid shortages
India's NPPA approved a 50% price hike for carboplatin and cisplatin, citing rising platinum costs, to address accessibility concerns for these critical anti-cancer medicines.
Confronto fonti
5 prospettive sulla stessa storiaTimeline cronologica
- ·
economictimes.indiatimes.com
Indian cancer patients battle shortage of key drugs as platinum costs surge
Cancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues are causing shortages. This forces…
- ·
nu.nl
Indiase kankerpatiënten kampen met tekort medicijnen door prijsstijging platina
Kankerpatiënten in India hebben grote moeite essentiële geneesmiddelen op basis van platina te vinden. Dat komt door problemen met levering en de sterk gestegen prijzen. Sommige…
- ·
thehindubusinessline.com
Cancer patients battle shortage of key drugs as platinum costs surge
Cancer patients in India face a severe shortage of platinum-based drugs due to rising costs and supply disruptions.
- ·
Centre approves price increase on “backbone of chemotherapy” drugs amid shortages
The Centre approves price hike for chemotherapy drugs Cisplatin and Carboplatin amid ongoing shortages in hospitals.
- ·
Government may lift price cap on cancer drugs making them costlier by up to 50%
India's government is taking emergency steps to ensure cancer patients get vital drugs. Cisplatin and carboplatin, crucial chemotherapy agents, faced shortages due to rising raw…
- ·
Cancer drug prices raised 50% as NPPA acts on shortage concerns
India's drug pricing authority has approved a 50% price hike for essential anti-cancer drugs carboplatin and cisplatin. This decision follows pleas from manufacturers citing…
- ·
India raises price cap on cancer drugs to tackle shortage
India's drug price regulator has increased the ceiling prices of cancer drugs cisplatin and carboplatin by 50% to tackle shortages caused by a sharp rise in platinum costs. The…
- ·
Cancer: NPPA raises price cap on key drugs amid shortage
India raises price caps on key cancer drugs by 50% to address shortages caused by rising raw material costs.
- ·
thehindu.com
Price cap on cancer drugs increase to tackle shortage
NPPA raises price caps on cisplatin and carboplatin by 50% to address critical shortages of essential cancer drugs.
- ·
newsbytesapp.com
India hikes cancer drug prices by 50% amid shortages
India's NPPA approved a 50% price hike for carboplatin and cisplatin, citing rising platinum costs, to address accessibility concerns for these critical anti-cancer medicines.
- ·
NPPA hikes Cisplatin and Carboplatin prices by 50% amid cancer drug shortage
NPPA raises prices of chemotherapy drugs Cisplatin and Carboplatin by 50% after shortages, aiming to improve availability of critical cancer medicines.